Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a))
- PMID: 2149268
- DOI: 10.1016/0021-9150(90)90088-z
Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. II. Preferential immobilization of lipoprotein (a) (Lp(a))
Abstract
The extracellular lipid that accumulates in fibrous atherosclerotic lesions appears to be derived directly from plasma low density lipoprotein (LDL). One factor that may influence the lipid deposition is immobilization of part of the LDL in lesions, and an immobilized fraction can be released by incubation with the fibrinolytic enzyme, plasmin, suggesting that it is associated with fibrin. The lipoprotein variant Lp(a) is associated with increased risk of arterial disease, and its characteristic apoprotein, apo(a), is structurally related to plasminogen, suggesting that it might bind to the plasminogen binding sites on fibrin. In this study we have compared blood Lp(a) and the soluble and plasmin-releasable Lp(a) in 45 samples of normal intima and different types of lesion. Levels of soluble and plasmin-releasable Lp(a) were dependent on both blood level and type of tissue sample. Although the amount of soluble LDL was 5-20 times higher than Lp(a) in intima, the amounts released by plasmin were similar, and Lp(a) appears to account for most of the apo B-containing lipoprotein that is immobilized in lesions.
Similar articles
-
Fibrinogen/fibrin in atherogenesis.Eur J Epidemiol. 1992 May;8 Suppl 1:83-7. doi: 10.1007/BF00145356. Eur J Epidemiol. 1992. PMID: 1387095 Review.
-
The inter-relation of fibrin, lipoprotein(a) and plasminogen in human atherosclerotic lesions.Blood Coagul Fibrinolysis. 1990 Oct;1(4-5):495-8. doi: 10.1097/00001721-199010000-00024. Blood Coagul Fibrinolysis. 1990. PMID: 2151935
-
Factors influencing the accumulation in fibrous plaques of lipid derived from low density lipoprotein. I. Relation between fibrin and immobilization of apo B-containing lipoprotein.Atherosclerosis. 1990 Oct;84(2-3):165-71. doi: 10.1016/0021-9150(90)90087-y. Atherosclerosis. 1990. PMID: 2149267
-
Does lipoprotein(a) (Lp(a)) complete with plasminogen in human atherosclerotic lesions and thrombi?Atherosclerosis. 1991 Aug;89(2-3):127-36. doi: 10.1016/0021-9150(91)90052-5. Atherosclerosis. 1991. PMID: 1838924
-
Lipoprotein Lp(a) and atherothrombotic disease.Arch Med Res. 2000 Jul-Aug;31(4):353-9. doi: 10.1016/s0188-4409(00)00084-9. Arch Med Res. 2000. PMID: 11068075 Review.
Cited by
-
Fibrinogen/fibrin in atherogenesis.Eur J Epidemiol. 1992 May;8 Suppl 1:83-7. doi: 10.1007/BF00145356. Eur J Epidemiol. 1992. PMID: 1387095 Review.
-
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.Molecules. 2023 Jan 18;28(3):969. doi: 10.3390/molecules28030969. Molecules. 2023. PMID: 36770634 Free PMC article. Review.
-
Effects of altered plasminogen activator inhibitor-1 expression on cardiovascular disease.Curr Drug Targets. 2011 Nov;12(12):1782-9. doi: 10.2174/138945011797635803. Curr Drug Targets. 2011. PMID: 21707474 Free PMC article. Review.
-
The response-to-retention hypothesis of early atherogenesis.Arterioscler Thromb Vasc Biol. 1995 May;15(5):551-61. doi: 10.1161/01.atv.15.5.551. Arterioscler Thromb Vasc Biol. 1995. PMID: 7749869 Free PMC article. Review. No abstract available.
-
Lipoprotein(a) in cardiovascular diseases.Biomed Res Int. 2013;2013:650989. doi: 10.1155/2013/650989. Epub 2012 Dec 30. Biomed Res Int. 2013. PMID: 23484137 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous